Literature DB >> 23204182

High interleukin 17 expression is correlated with better cardiac function in human Chagas disease.

Luisa M D Magalhães1, Fernanda N A Villani, Maria do Carmo P Nunes, Kenneth J Gollob, Manoel O C Rocha, Walderez O Dutra.   

Abstract

This study was designed to investigate whether the expression of interleukin 17 (IL-17) is associated with the indeterminate or cardiac clinical forms of Chagas disease and whether IL-17 expression can be correlated with patients' cardiac function. Our results demonstrated that cardiac Chagas patients have a lower intensity of expression of IL-17 by total lymphocytes and lower frequency of circulating T helper 17 cells. Correlative analysis showed that high IL-17 expression was associated with better cardiac function, as determined by left ventricular ejection fraction and left ventricular diastolic diameter values. Therefore, IL-17 expression can be a protective factor to prevent myocardial damage in human Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23204182      PMCID: PMC3611763          DOI: 10.1093/infdis/jis724

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  An update on the management of Chagas cardiomyopathy.

Authors:  Manoel O C Rocha; Mauro M Teixeira; Antonio L Ribeiro
Journal:  Expert Rev Anti Infect Ther       Date:  2007-08       Impact factor: 5.091

Review 2.  Th17: an effector CD4 T cell lineage with regulatory T cell ties.

Authors:  Casey T Weaver; Laurie E Harrington; Paul R Mangan; Maya Gavrieli; Kenneth M Murphy
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

3.  Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy.

Authors:  Germano C Costa; Manoel Otávio da Costa Rocha; Paula Rocha Moreira; Cristiane Alves Silva Menezes; Micena R Silva; Kenneth J Gollob; Walderez O Dutra
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

4.  Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease.

Authors:  Walderez Ornelas Dutra; Cristiane Alves Silva Menezes; Fernanda Nobre Amaral Villani; Germano Carneiro da Costa; Alexandre Barcelos Morais da Silveira; Débora d'Avila Reis; Kenneth J Gollob
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

5.  Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.

Authors:  F F de Araújo; R Corrêa-Oliveira; M O C Rocha; A T Chaves; J A Fiuza; R C G Fares; K S Ferreira; M C P Nunes; T S Keesen; M P S Damasio; A Teixeira-Carvalho; J A S Gomes
Journal:  Immunobiology       Date:  2012-05-09       Impact factor: 3.144

6.  Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity.

Authors:  Paulo E A Souza; Manoel O C Rocha; Etel Rocha-Vieira; Cristiane A S Menezes; Andréa C L Chaves; Kenneth J Gollob; Walderez O Dutra
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 7.  Th17 cells in human disease.

Authors:  Laura A Tesmer; Steven K Lundy; Sujata Sarkar; David A Fox
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

8.  An estimate of the burden of Chagas disease in the United States.

Authors:  Caryn Bern; Susan P Montgomery
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

9.  Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis.

Authors:  Thomas J Bahk; Melvin D Daniels; Juan S Leon; Kegiang Wang; David M Engman
Journal:  Int J Cardiol       Date:  2007-06-22       Impact factor: 4.164

10.  Bradykinin B2 Receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses.

Authors:  Ana Carolina Monteiro; Verônica Schmitz; Alexandre Morrot; Luciana Barros de Arruda; Fnu Nagajyothi; Alessandra Granato; João B Pesquero; Werner Müller-Esterl; Herbert B Tanowitz; Julio Scharfstein
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

View more
  36 in total

1.  Interleukin-17 mediated immunity during infections with Trypanosoma cruzi and other protozoans.

Authors:  María Carolina Amezcua Vesely; Constanza Rodríguez; Adriana Gruppi; Eva Virginia Acosta Rodríguez
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-24       Impact factor: 5.187

2.  A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.

Authors:  Carylinda Serna; Joshua A Lara; Silas P Rodrigues; Alexandre F Marques; Igor C Almeida; Rosa A Maldonado
Journal:  Vaccine       Date:  2014-04-30       Impact factor: 3.641

3.  Investigation of the role of IL17A gene variants in Chagas disease.

Authors:  D A Leon Rodriguez; L E Echeverría; C I González; J Martin
Journal:  Genes Immun       Date:  2015-10-15       Impact factor: 2.676

Review 4.  Immunoregulatory networks in human Chagas disease.

Authors:  W O Dutra; C A S Menezes; L M D Magalhães; K J Gollob
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

5.  Specific activation of CD4- CD8- double-negative T cells by Trypanosoma cruzi-derived glycolipids induces a proinflammatory profile associated with cardiomyopathy in Chagas patients.

Authors:  L S A Passos; L M D Magalhães; R P Soares; A F Marques; M do C P Nunes; K J Gollob; W O Dutra
Journal:  Clin Exp Immunol       Date:  2017-07-03       Impact factor: 4.330

Review 6.  Oxidative stress implications for therapeutic vaccine development against Chagas disease.

Authors:  Subhadip Choudhuri; Lizette Rios; Juan Carlos Vázquez-Chagoyán; Nisha Jain Garg
Journal:  Expert Rev Vaccines       Date:  2021-08-30       Impact factor: 5.217

7.  Systemic cytokines, chemokines and growth factors reveal specific and shared immunological characteristics in infectious cardiomyopathies.

Authors:  Eula G A Neves; Carolina C Koh; José L Padilha da Silva; Lívia S A Passos; Fernanda N A Villani; Janete S C Dos Santos; Cristiane A S Menezes; Vicente R Silva; Julia P A S Tormin; Guilherme F B Evangelista; Andréa Teixeira de Carvalho; Manoel Otávio da Costa Rocha; Bruno Nascimento; Kenneth John Gollob; Maria do Carmo P Nunes; Walderez O Dutra
Journal:  Cytokine       Date:  2021-09-27       Impact factor: 3.861

Review 8.  Central role of metabolism in Trypanosoma cruzi tropism and Chagas disease pathogenesis.

Authors:  Zongyuan Liu; Rebecca Ulrich vonBargen; Laura-Isobel McCall
Journal:  Curr Opin Microbiol       Date:  2021-08-26       Impact factor: 7.584

Review 9.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

10.  Th17 Cells Provide Mucosal Protection against Gastric Trypanosoma cruzi Infection.

Authors:  Catherine W Cai; Christopher S Eickhoff; Krystal A Meza; Jennifer R Blase; Rebecca E Audette; David H Chan; Kevin A Bockerstett; Richard J DiPaolo; Daniel F Hoft
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.